サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：臨床試験管理サービス市場：規模、シェア、動向分析レポート：サービス別、業界別、適応症別、地域別、セグメント別予測（2022年～2030年）
市場調査レポート
商品コード
1171130

臨床試験管理サービス市場：規模、シェア、動向分析レポート：サービス別、業界別、適応症別、地域別、セグメント別予測（2022年～2030年）

Clinical Trial Management Services Market Size, Share & Trends Analysis Report By Services (Clinical Trial Monitoring, Regulatory Submissions), By Industry, By Indication, By Region, And Segment Forecasts, 2022 - 2030
出版日: | 発行: Grand View Research | ページ情報: 英文 275 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
臨床試験管理サービス市場：規模、シェア、動向分析レポート：サービス別、業界別、適応症別、地域別、セグメント別予測（2022年～2030年）
出版日: 2022年11月07日
発行: Grand View Research
ページ情報: 英文 275 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の臨床試験管理サービスの市場規模は、2022年～2030年の予測期間中に7.5%のCAGRで拡大し、2030年までに521億米ドルに達すると予測されています。

臨床試験活動のアウトソーシング傾向の高まり、先進的な治療法の研究開発の増加、臨床試験の世界化などが、市場の成長を促す主な要因となっています。

当レポートでは、世界の臨床試験管理サービス市場について調査し、市場の現状とともに、サービス別、業界別、適応症別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 臨床試験管理サービス市場の変数、動向、範囲

  • 市場系列の見通し
  • 浸透と成長の見通しのマッピング
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
    • 浸透と成長の見通しのマッピング
    • COVID-19の影響と回復の分析
    • 主要取引と戦略的提携分析
    • 業界分析- ポーターのファイブフォース
    • PESTLE分析

第4章 臨床試験管理サービス市場：サービス別セグメント分析

  • 臨床試験管理サービス市場：定義と範囲
  • 臨床試験管理サービス市場：サービス別市場シェア分析、2021年および2030年
    • 臨床試験モニタリング
    • 規制当局への提出
    • 臨床試験データ管理
    • メディカルライティング
    • サイト管理と監視
    • その他

第5章 臨床試験管理サービス市場：業界別セグメント分析

  • 臨床試験管理サービス市場：定義と範囲
  • 臨床試験管理サービス市場：業界別市場シェア分析、2021年および2030年
    • 医薬品
    • バイオ医薬品
    • 医療機器

第6章 臨床試験管理サービス市場：適応症別セグメント分析

  • 臨床試験管理サービス市場：定義と範囲
  • 臨床試験管理サービス市場：適応症別市場シェア分析、2021年および2030年
    • 免疫学
    • 血液学
    • 腫瘍学
    • 神経学
    • 皮膚科
    • その他

第7章 臨床試験管理サービス市場：地域別分析

  • 臨床試験管理サービス：地域別市場シェア分析、2021年および2030年
  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ

第8章 競合情勢

  • 臨床試験管理サービス市場：企業の市場シェア分析、2021年および2030年
  • 企業プロファイル
    • SGS
    • LabCorp
    • IQVIA, Inc.
    • Syneous Health
    • Atlantic Research Group
    • ICON PLC
    • Clinical Trial &Consulting Services
    • Charles River Laboratories
    • Med pace
    • Wuxi Apptec
図表

List of Tables

  • Table 1 List of Secondary sources
  • Table 2 List of Abbreviations

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 QFD modeling for market share assessment
  • Fig. 6 Market formulation & validation
  • Fig. 7 Commodity flow analysis
  • Fig. 8 Volume price analysis
  • Fig. 9 Clinical trial management services market snapshot (2021)
  • Fig. 10 Clinical trial management services market segmentation
  • Fig. 11 Heat map analysis
  • Fig. 12 Parent market outlook
  • Fig. 13 Ancillary market outlook
  • Fig. 14 Penetration & growth prospect mapping
  • Fig. 15 Market driver relevance analysis (Current & future impact)
  • Fig. 16 Market restraint relevance analysis (Current & future impact)
  • Fig. 17 Porter's five forces analysis
  • Fig. 18 SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 19 Clinical trial management services market services outlook: Segment dashboard
  • Fig. 20 Clinical trial management services market: Services movement analysis
  • Fig. 21 Clinical trial monitoring market, 2018 - 2030 (USD Million)
  • Fig. 22 Regulatory submissions market, 2018 - 2030 (USD Million)
  • Fig. 23 Clinical trial data management market, 2018 - 2030 (USD Million)
  • Fig. 24 Medical writing market, 2018 - 2030 (USD Million)
  • Fig. 25 Site management & monitoring market, 2018 - 2030 (USD Million)
  • Fig. 26 Others market, 2018 - 2030 (USD Million)
  • Fig. 27 Clinical trial management services market industry outlook: Segment dashboard
  • Fig. 28 Clinical trial management services market: Industry movement analysis
  • Fig. 29 Pharmaceuticals market, 2018 - 2030 (USD Million)
  • Fig. 30 Biopharmaceuticals market, 2018 - 2030 (USD Million)
  • Fig. 31 Medical devices market, 2018 - 2030 (USD Million)
  • Fig. 32 Clinical trial management services market indication outlook: Segment dashboard
  • Fig. 33 Clinical trial management services market: Indication movement analysis
  • Fig. 34 Immunology testing market, 2018 - 2030 (USD Million)
  • Fig. 35 Hematology market, 2018 - 2030 (USD Million)
  • Fig. 36 Oncology market, 2018 - 2030 (USD Million)
  • Fig. 37 Neurology market, 2018 - 2030 (USD Million)
  • Fig. 38 Other tests market, 2018 - 2030 (USD Million)
  • Fig. 39 Regional market: Key takeaways
  • Fig. 40 Clinical trial management services market: Regional movement analysis
  • Fig. 41 North America. market, 2018 - 2030 (USD Million)
  • Fig. 42 U.S. market, 2018 - 2030 (USD Million)
  • Fig. 43 Canada market, 2018 - 2030 (USD Million)
  • Fig. 44 Europe market, 2018 - 2030 (USD Million)
  • Fig. 45 U.K. market, 2018 - 2030 (USD Million)
  • Fig. 46 Germany market, 2018 - 2030 (USD Million)
  • Fig. 47 France market, 2018 - 2030 (USD Million)
  • Fig. 48 Italy market, 2018 - 2030 (USD Million)
  • Fig. 49 Spain market, 2018 - 2030 (USD Million)
  • Fig. 50 Asia Pacific market, 2018 - 2030 (USD Million)
  • Fig. 51 Japan market, 2018 - 2030 (USD Million)
  • Fig. 52 China market, 2018 - 2030 (USD Million)
  • Fig. 53 India market, 2018 - 2030 (USD Million)
  • Fig. 54 Australia market, 2018 - 2030 (USD Million)
  • Fig. 55 Latin America market, 2018 - 2030 (USD Million)
  • Fig. 56 Brazil market, 2018 - 2030 (USD Million)
  • Fig. 57 Mexico market, 2018 - 2030 (USD Million)
  • Fig. 58 Argentina market, 2018 - 2030 (USD Million)
  • Fig. 59 MEA market, 2018 - 2030 (USD Million)
  • Fig. 60 South Africa market, 2018 - 2030 (USD Million)
  • Fig. 61 Saudi Arabia market, 2018 - 2030 (USD Million)
  • Fig. 62 UAE market, 2018 - 2030 (USD Million)
目次
Product Code: GVR-4-68039-993-8

Clinical Trial Management Services Market Growth & Trends:

The global clinical trial management services market size is anticipated to reach USD 52.1 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 7.5% from 2022 to 2030. The increasing trend of outsourcing clinical trial activities, the rise in research and development of advanced therapies, and the globalization of clinical trials are a few key factors driving the growth of the market.

The number of clinical trials has significantly increased in the past two decades. This is due to the rising need for novel pharmaceutical products with improved efficacy as well as the increasing penetration of cutting-edge medical technologies. According to Clinical trials.gov, the total number of clinical trials accounted for 325,773 in 2020, whereas, as of April 2022, the number of clinical trials this year totaled more than 410,903.

Clinical trial management services such as clinical monitoring, data management, site monitoring, and medical writing service are cost-effective and time-saving. These also harmonize clinical data across sites and failure rates. Furthermore, the integration of digital technologies, including cloud computing, Artificial Intelligence (AI), big data prescriptive, and predictive analytics, the Internet of Medical Things, and mobile technology remain major developments on the horizon. These technologies have shown great promise in improving productivity while accelerating the pace of clinical trials.

The COVID-19 pandemic significantly impacted the market. It created an unexpected urgency for alternative solutions to clinical trial execution, limiting on-site monitoring visits. It prompted researchers to use remote clinical trial monitoring services and platforms to reduce the spread of the COVID-19 infection as well as to simultaneously function in clinical research. For instance, according to the Florence survey in 2020, more than 60% of clinical study sites and clinical trial sponsors stated more than 50% acceptance of remote site monitoring solutions for clinical research.

Clinical Trial Management Services Market Report Highlights:

  • The clinical trial monitoring segment dominated the market with a revenue share of 31.6% in 2021. Technological advancement in trial monitoring is one of the key factors driving the growth of the market.
  • The oncology segment is anticipated to hold the highest market share of 31.0% in 2021 in the clinical trial management services market. High shares of the segment are majorly due to the increasing cases of cancer across the globe.
  • Based on industry, pharmaceuticals accounted for the largest market share of 38.9% in 2021. The companies have adopted technologies such as cloud computing and AI to improve patient engagement and reduce trial failures to drive market growth.
  • Asia Pacific is projected to witness the fastest CAGR-driven growth of 8.5% during the forecast period. Factors such as the cheap labor cost, a diverse patient pool, lowered costs of clinical trial activities

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Services
    • 1.1.2. Industry
    • 1.1.3. Indication
    • 1.1.4. Regional scope
    • 1.1.5. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.2. Volume price analysis (Model 2)
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2
    • 1.9.3. Objective 3
    • 1.9.4. Objective 4

Chapter 2. Executive Summary

  • 2.1. Market Outlook

Chapter 3. Clinical Trial Management Services Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
      • 3.3.1.1. Increasing technological advancement in the clinical trial monitoring services
      • 3.3.1.2. Rise in R&D expenditure by pharmaceutical and biopharmaceutical companies
      • 3.3.1.3. Growth in the number of outsourced projects related to clinical trial management services
    • 3.3.2. Market restraint analysis
      • 3.3.2.1. High cost associated with clinical trial management services
      • 3.3.2.2. Stringent regulatory policies for clinical trial management services
    • 3.3.3. Penetration & Growth Prospect Mapping
    • 3.3.4. Covid-19 Impact & Recovery Analysis
    • 3.3.5. Major Deals and Strategic Alliances Analysis
    • 3.3.6. Industry Analysis - Porter's Five Forces
    • 3.3.7. PESTLE Analysis

Chapter 4. Clinical Trial Management Services Market: Services Segment Analysis

  • 4.1. Clinical Trial Management Services Market: Definition & Scope
  • 4.2. Clinical Trial Management Services Market: Services Market Share Analysis, 2021 & 2030
    • 4.2.1. Clinical Trial Monitoring
      • 4.2.1.1. Clinical Trial Monitoring Market, 2018 - 2030 (USD Million)
    • 4.2.2. Regulatory Submissions
      • 4.2.2.1. Regulatory Submissions Market, 2018 - 2030 (USD Million)
    • 4.2.3. Clinical Trial Data Management
      • 4.2.3.1. Clinical Trial Data Management Market, 2018 - 2030 (USD Million)
    • 4.2.4. Medical Writing
      • 4.2.4.1. Medical Writing Market, 2018 - 2030 (USD Million)
    • 4.2.5. Site management & monitoring
      • 4.2.5.1. Site management & monitoring Market, 2018 - 2030 (USD Million)
    • 4.2.6. Others
      • 4.2.6.1. Others Market, 2018 - 2030 (USD Million)

Chapter 5. Clinical Trial Management Services Market: Industry Segment Analysis

  • 5.1. Clinical Trial Management Services Market: Definition & Scope
  • 5.2. Clinical Trial Management Services Market: Industry Market Share Analysis, 2021 & 2030
    • 5.2.1. Pharmaceuticals
      • 5.2.1.1. Pharmaceuticals Market, 2018 - 2030 (USD Million)
    • 5.2.2. Biopharmaceuticals
      • 5.2.2.1. Biopharmaceuticals Market, 2018 - 2030 (USD Million)
    • 5.2.3. Medical Devices
      • 5.2.3.1. Medical Devices Market, 2018 - 2030 (USD Million)

Chapter 6. Clinical Trial Management Services Market: Indication Segment Analysis

  • 6.1. Clinical Trial Management Services Market: Definition & Scope
  • 6.2. Clinical Trial Management Services Market: Indication Market Share Analysis, 2021 & 2030
    • 6.2.1. Immunology
      • 6.2.1.1. Immunology Market, 2018 - 2030 (USD Million)
    • 6.2.2. Hematology
      • 6.2.2.1. Hematology Market, 2018 - 2030 (USD Million)
    • 6.2.3. Oncology
      • 6.2.3.1. Oncology Market, 2018 - 2030 (USD Million)
    • 6.2.4. Neurology
      • 6.2.4.1. Neurology Market, 2018 - 2030 (USD Million)
    • 6.2.5. Dermatology
      • 6.2.5.1. Oncology Market, 2018 - 2030 (USD Million)
    • 6.2.6. Others
      • 6.2.6.1. Others Market, 2018 - 2030 (USD Million)

Chapter 7. Clinical Trial Management Services Market: Regional Analysis

  • 7.1. Clinical Trial Management Services: Regional market share analysis, 2021 & 2030
  • 7.2. North America
    • 7.2.1. U.S. Clinical Trial Management Services Market, 2018 - 2030 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. U.S. Clinical Trial Management Services Market, 2018 - 2030 (USD Million)
    • 7.2.3. Canada
      • 7.2.3.1. Canada Clinical Trial Management Services Market, 2018 - 2030 (USD Million)
  • 7.3. Europe
    • 7.3.1. Europe Clinical Trial Management Services Market, 2018 - 2030 (USD Million)
    • 7.3.2. U.K.
      • 7.3.2.1. U.K. Clinical Trial Management Services Market, 2018 - 2030 (USD Million)
    • 7.3.3. Germany
      • 7.3.3.1. Germany Clinical Trial Management Services Market, 2018 - 2030 (USD Million)
    • 7.3.4. Italy
      • 7.3.4.1. Italy Clinical Trial Management Services Market, 2018 - 2030 (USD Million)
    • 7.3.5. Spain
      • 7.3.5.1. Spain Clinical Trial Management Services Market, 2018 - 2030 (USD Million)
    • 7.3.6. France
      • 7.3.6.1. France Clinical Trial Management Services Market, 2018 - 2030 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific Clinical Trial Management Services Market, 2018 - 2030 (USD Million)
    • 7.4.2. China
      • 7.4.2.1. China Clinical Trial Management Services Market, 2018 - 2030 (USD Million)
    • 7.4.3. India
      • 7.4.3.1. India Clinical Trial Management Services Market, 2018 - 2030 (USD Million)
    • 7.4.4. Japan
      • 7.4.4.1. Japan Clinical Trial Management Services Market, 2018 - 2030 (USD Million)
    • 7.4.5. Australia
      • 7.4.5.1. Australia Clinical Trial Management Services Market, 2018 - 2030 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Latin America Clinical Trial Management Services Market, 2018 - 2030 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Brazil Clinical Trial Management Services Market, 2018 - 2030 (USD Million)
    • 7.5.3. Mexico
      • 7.5.3.1. Mexico Clinical Trial Management Services Market, 2018 - 2030 (USD Million)
    • 7.5.4. Argentina
      • 7.5.4.1. Argentina Clinical Trial Management Services Market, 2018 - 2030 (USD Million)
  • 7.6. MEA
    • 7.6.1. MEA Clinical Trial Management Services Market, 2018 - 2030 (USD Million)
    • 7.6.2. South Africa
      • 7.6.2.1. South Africa Clinical Trial Management Services Market, 2018 - 2030 (USD Million)
    • 7.6.3. South Arabia
      • 7.6.3.1. South Africa Clinical Trial Management Services Market, 2018 - 2030 (USD Million)
    • 7.6.4. UAE
      • 7.6.4.1. UAE Clinical Trial Management Services Market, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Clinical Trial Management Services: Company market share analysis, 2021 & 2030
  • 8.2. Company Profiles
    • 8.2.1. SGS
      • 8.2.1.1. Company overview
      • 8.2.1.2. Financial performance
      • 8.2.1.3. Service benchmarking
      • 8.2.1.4. Strategic initiatives
    • 8.2.2. LabCorp
      • 8.2.2.1. Company overview
      • 8.2.2.2. Financial performance
      • 8.2.2.3. Service benchmarking
      • 8.2.2.4. Strategic initiatives
    • 8.2.3. IQVIA, Inc.
      • 8.2.3.1. Company overview
      • 8.2.3.2. Financial performance
      • 8.2.3.3. Service benchmarking
      • 8.2.3.4. Strategic initiatives
    • 8.2.4. Syneous Health
      • 8.2.4.1. Company overview
      • 8.2.4.2. Financial performance
      • 8.2.4.3. Service benchmarking
      • 8.2.4.4. Strategic initiatives
    • 8.2.5. Atlantic Research Group
      • 8.2.5.1. Company overview
      • 8.2.5.2. Financial performance
      • 8.2.5.3. Service benchmarking
      • 8.2.5.4. Strategic initiatives
    • 8.2.6. ICON PLC
      • 8.2.6.1. Company overview
      • 8.2.6.2. Financial performance
      • 8.2.6.3. Service benchmarking
      • 8.2.6.4. Strategic initiatives
    • 8.2.7. Clinical Trial & Consulting Services
      • 8.2.7.1. Company overview
      • 8.2.7.2. Financial performance
      • 8.2.7.3. Service benchmarking
      • 8.2.7.4. Strategic initiatives
    • 8.2.8. Charles River Laboratories
      • 8.2.8.1. Company overview
      • 8.2.8.2. Financial performance
      • 8.2.8.3. Service benchmarking
      • 8.2.8.4. Strategic initiatives
    • 8.2.9. Med pace
      • 8.2.9.1. Company overview
      • 8.2.9.2. Financial performance
      • 8.2.9.3. Service benchmarking
      • 8.2.9.4. Strategic initiatives
    • 8.2.10. Wuxi Apptec
      • 8.2.10.1. Company overview
      • 8.2.10.2. Financial performance
      • 8.2.10.3. Service benchmarking
      • 8.2.10.4. Strategic initiatives